创新医疗
(002173)
| 流通市值：42.46亿 | | | 总市值：45.01亿 |
| 流通股本：4.16亿 | | | 总股本：4.41亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 163,567,040.65 | 137,984,131.56 | 547,164,141.38 | 555,534,972.1 |
| 应收票据及应收账款 | 128,385,494.42 | 124,184,225.79 | 111,110,613.96 | 124,121,064.22 |
| 应收账款 | 128,385,494.42 | 124,184,225.79 | 111,110,613.96 | 124,121,064.22 |
| 预付款项 | 4,631,423.46 | 4,649,527.59 | 3,359,624.47 | 2,700,535.54 |
| 其他应收款合计 | 1,984,981.78 | 1,263,450.56 | 2,459,106.47 | 2,030,728.66 |
| 存货 | 33,351,878.23 | 42,006,581.47 | 38,960,002.85 | 36,111,389.88 |
| 其他流动资产 | 978,399.07 | 965,364.63 | 1,396,479.65 | 1,324,321.27 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 566,946,305.73 | 598,852,540.99 | 717,701,375.28 | 732,609,697.47 |
| 非流动资产: | | | | |
| 长期股权投资 | 39,648,629.81 | 41,746,715.83 | 13,101,441.86 | 13,886,733.09 |
| 固定资产 | 1,226,426,606.28 | 1,239,794,066.87 | 1,259,849,268.92 | 1,277,734,263.3 |
| 在建工程 | 9,967,610.39 | 9,451,323.39 | 3,745,623.56 | 2,401,570.15 |
| 使用权资产 | 22,007,238.9 | 24,158,795.46 | 26,668,744.49 | 29,027,952.17 |
| 无形资产 | 125,898,902.6 | 127,413,695.7 | 129,505,154.05 | 130,932,445.55 |
| 商誉 | 986,746.86 | 986,746.86 | 986,746.86 | 986,746.86 |
| 长期待摊费用 | 29,921,910.49 | 31,837,743.67 | 34,712,750.31 | 35,626,249.14 |
| 递延所得税资产 | 24,783,186.59 | 24,792,494.45 | 19,577,031.11 | 17,460,487.09 |
| 其他非流动资产 | 117,454,468.75 | 104,913,585.19 | 14,148,327.62 | 2,080,502.97 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,597,095,300.67 | 1,605,095,167.42 | 1,502,295,088.78 | 1,510,136,950.32 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,164,041,606.4 | 2,203,947,708.41 | 2,219,996,464.06 | 2,242,746,647.79 |
| 流动负债: | | | | |
| 短期借款 | 46,056,465.96 | 41,056,466.06 | 41,051,332.73 | 43,000,000 |
| 应付票据及应付账款 | 187,395,167.34 | 195,242,664.18 | 191,933,745.75 | 198,531,366.77 |
| 其中：应付票据 | - | 1,000,000 | - | - |
| 应付账款 | 187,395,167.34 | 194,242,664.18 | 191,933,745.75 | 198,531,366.77 |
| 预收款项 | 152,083.34 | 163,083.34 | 38,357.94 | 38,333.34 |
| 合同负债 | 4,542,201.54 | 3,576,849.58 | 3,134,146.92 | 3,792,270.65 |
| 应付职工薪酬 | 32,131,611.95 | 47,015,597.16 | 33,952,172.63 | 31,819,783.29 |
| 应交税费 | 3,609,909.35 | 8,591,645.76 | 6,967,926.12 | 5,341,616.66 |
| 其他应付款合计 | 15,695,344.86 | 13,567,380.05 | 13,601,991.82 | 14,783,101.49 |
| 一年内到期的非流动负债 | 10,094,471.51 | 11,983,473.22 | 15,832,231.32 | 15,898,349.22 |
| 其他流动负债 | 11,504.42 | 11,504.42 | - | - |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 299,688,760.27 | 321,208,663.77 | 306,511,905.23 | 313,204,821.42 |
| 非流动负债: | | | | |
| 长期借款 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 |
| 租赁负债 | 10,992,011.45 | 15,139,272.49 | 13,744,414.1 | 16,250,913.44 |
| 预计负债 | 34,964,602.39 | 34,930,425.21 | 445,814.13 | 1,934,561.07 |
| 递延收益 | 43,796,077.84 | 44,023,165.01 | 3,702,699.42 | 3,858,058.59 |
| 递延所得税负债 | 3,391,981.08 | 3,547,340.25 | 44,201,376.76 | 44,296,329.82 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 101,144,672.76 | 105,640,202.96 | 70,094,304.41 | 74,339,862.92 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 400,833,433.03 | 426,848,866.73 | 376,606,209.64 | 387,544,684.34 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 441,284,352 | 441,284,352 | 441,284,352 | 441,284,352 |
| 资本公积 | 2,708,003,168.7 | 2,708,003,168.7 | 2,708,003,168.7 | 2,708,003,168.7 |
| 盈余公积 | 25,102,306.36 | 25,102,306.36 | 25,102,306.36 | 25,102,306.36 |
| 未分配利润 | -1,412,129,160.15 | -1,398,191,741.89 | -1,332,081,858.74 | -1,320,267,304.76 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,762,260,666.91 | 1,776,198,085.17 | 1,842,307,968.32 | 1,854,122,522.3 |
| 少数股东权益 | 947,506.46 | 900,756.51 | 1,082,286.1 | 1,079,441.15 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,763,208,173.37 | 1,777,098,841.68 | 1,843,390,254.42 | 1,855,201,963.45 |
| 负债和股东权益合计 | 2,164,041,606.4 | 2,203,947,708.41 | 2,219,996,464.06 | 2,242,746,647.79 |
| 公告日期 | 2025-04-28 | 2025-04-12 | 2024-10-25 | 2024-08-10 |
| 审计意见(境内) | | 标准无保留意见 | | |